ACELLYTRON THERAPEUTICS
Live / Registered — Registered (as of 20 May 2025)
What this means for you
Registered since 20 May 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79406657
- Registration number
- 7797742
- Mark type
- Design + words
- Filed
- 08 Mar 2024
- Published for opposition
- 01 Apr 2025
- Registered
- 20 May 2025
- Attorney of record
- Michael T. Smith
Goods and services
- Class 005 — Pharmaceuticals: Chemical-pharmaceutical preparations for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; biochemical medicines for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; vaccine preparations; influenza vaccine; chemotherapeutics; stem cells for medical purposes; medicines for human purposes for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; drugs for medical purposes, namely, medicines for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; pharmaceutical preparations for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; drugs for treatment of cancer; medical preparation for treating diseases and disorders related to the immune system; biological agent, namely, biological preparations for treating cancer; pharmaceutical preparations for the prevention and treatment of cancer; living cells for medical use; medical cell inhibitor for inhibiting the growth of cancer cells; reagents for medical purposes; anticancer agent; diagnostic reagents for medical purposes; pharmaceutical preparations, namely, tumor suppressor; cells for medical use; dietetic infusions, sugar, foods, and beverages substances adapted for medical use; biological preparations for veterinary purposes for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer
- Class 035 — Advertising and business services: Online advertising on a computer network; advertising services; publicity agents; dissemination of advertising and advertising matter in the nature of flyers, prospectuses, brochures, leaflets and samples; providing commercial information and advice for consumers in the choice of products and services; organization of exhibitions and trade fairs for commercial or advertising purposes; import-export agency services; marketing; sponsorship search; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies
- Class 042 — Scientific and technological services: Research and development of new products for others; technological research in the field of chemical and biological medicaments; chemical analysis; biochemical research and analysis; research and development in the field of pharmaceutical preparations; medical research service; research and development of services in the field of antibodies; stem cell research services; medical research; medical and scientific research, namely, conducting clinical trials for others; biological research; computer programming in the field of medical aspects
- Class 044 — Medical, beauty and agricultural services: Preparation of prescriptions by pharmacists; stem cell therapy services; medical clinic services; providing medical information; DNA screening for medical purposes; medical analysis services for the diagnosis of cancer; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening; health care; medical assistance
Owner
Prosecution history
- 26 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 09 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 09 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 08 Jan 2026 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 19 Dec 2025 — FINAL DISPOSITION NOTICE SENT TO IB
- 19 Dec 2025 — FINAL DISPOSITION PROCESSED
- 21 Aug 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 20 May 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 May 2025 — REGISTERED-PRINCIPAL REGISTER
- 01 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Apr 2025 — PUBLISHED FOR OPPOSITION
- 26 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE